Article
NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia
20 Jun 2024
Abstract excerpt
Introduction Acute myeloid leukemia (AML) is an aggressive blood cancer with high heterogeneity and poor prognosis. Although the metabolic reprogramming of nicotinamide adenine dinucleotide (NAD) has been reported to play a pivotal role in the pathogenesis of acute myeloid leukemia (AML), the prognostic value of NAD metabolism and its correlation with the immune microenvironment in AML remains unclear. Methods We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
